The Hyperthyroidism Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.1 billion by 2034, registering a CAGR of 5.2%. This growth trajectory is underpinned by several factors, including the rising prevalence of hyperthyroidism, increased awareness of thyroid disorders, and advancements in diagnostic and therapeutic technologies. The growing geriatric population, which...

The Hemiplegia Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.2 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising incidence of neurological disorders, advancements in rehabilitation technologies, and increasing awareness regarding hemiplegia management. The demand for effective treatment...

The Glycogen Storage Disease Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of glycogen storage diseases (GSD), advancements in diagnostic technologies, and the rising demand for effective treatment options. The market is...

The Erythematosus Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 10.1 billion by 2034, registering a CAGR of 6.8%. This growth trajectory is underpinned by several key factors, including the rising prevalence of erythematosus conditions, advancements in treatment options, and increasing awareness among healthcare professionals and patients. The demand for effective...

The Diabetic Ketoacidosis Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.2 billion by 2034, registering a CAGR of 8.0%. This growth trajectory is underpinned by several critical factors, including the rising prevalence of diabetes, increased awareness of diabetic complications, and advancements in treatment options. The demand for effective management solutions for...

The Bulimia Nervosa Treatment Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.5 billion by 2034, registering a CAGR of 6.2%. This growth trajectory is underpinned by increasing awareness of mental health issues, a growing number of healthcare initiatives aimed at addressing eating disorders, and the rising prevalence of bulimia nervosa among various demographics,...

The Behcets Disease Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several factors, including an increasing prevalence of Behcet’s disease, advancements in treatment options, and heightened awareness among healthcare professionals and patients. The rising incidence of this...

  The Axial Spondylarthritis Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.9 billion by 2034, registering a CAGR of 7.1%. This growth trajectory is underpinned by several key factors, including the rising prevalence of axial spondylarthritis, increased awareness and diagnosis rates, and advancements in treatment options. The market is characterized by a...

The Fruit Beer Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.2 billion by 2034, registering a CAGR of 8.1%. This growth trajectory is underpinned by an increasing consumer preference for unique flavors and healthier beverage options, as well as the rising popularity of craft breweries. The fruit beer segment, characterized by its innovative flavor profiles and...

The contact lenses market size is expected to reach USD 11.91 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Increase in refractive disorders among varying age groups, growing geriatric population, changing lifestyle, rapid urbanization, and increase in problems associated with diabetes are major factors boosting revenue...